chr1-235380161-T-TTGTG
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS1
The NM_003193.5(TBCE):c.100+62_100+65dupGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
 Genomes: 𝑓 0.0010   (  0   hom.,  cov: 0) 
 Exomes 𝑓:  0.00035   (  0   hom.  ) 
Consequence
 TBCE
NM_003193.5 intron
NM_003193.5 intron
Scores
 Not classified 
Clinical Significance
Conservation
 PhyloP100:  -0.401  
Publications
1 publications found 
Genes affected
 TBCE  (HGNC:11582):  (tubulin folding cofactor E) Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008] 
TBCE Gene-Disease associations (from GenCC):
- hypoparathyroidism-retardation-dysmorphism syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
 - early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndromeInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
 - encephalopathy, progressive, with amyotrophy and optic atrophyInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P
 - autosomal recessive Kenny-Caffey syndromeInheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -5 ACMG points.
BP6
Variant 1-235380161-T-TTGTG is Benign according to our data. Variant chr1-235380161-T-TTGTG is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 296290.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00101 (142/139956) while in subpopulation AMR AF = 0.00177 (24/13522). AF 95% confidence interval is 0.00122. There are 0 homozygotes in GnomAd4. There are 63 alleles in the male GnomAd4 subpopulation. Median coverage is 0. This position passed quality control check. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TBCE | NM_003193.5  | c.100+62_100+65dupGTGT | intron_variant | Intron 2 of 16 | ENST00000642610.2 | NP_003184.1 | ||
| TBCE | NM_001287801.2  | c.100+62_100+65dupGTGT | intron_variant | Intron 2 of 17 | NP_001274730.1 | |||
| TBCE | NM_001079515.3  | c.100+62_100+65dupGTGT | intron_variant | Intron 2 of 16 | NP_001072983.1 | |||
| TBCE | NM_001287802.2  | c.-211+62_-211+65dupGTGT | intron_variant | Intron 2 of 15 | NP_001274731.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TBCE | ENST00000642610.2  | c.100+12_100+13insTGTG | intron_variant | Intron 2 of 16 | NM_003193.5 | ENSP00000494796.1 | ||||
| ENSG00000285053 | ENST00000647186.1  | c.100+12_100+13insTGTG | intron_variant | Intron 4 of 18 | ENSP00000494775.1 | 
Frequencies
GnomAD3 genomes   AF:  0.00102  AC: 142AN: 139834Hom.:  0  Cov.: 0 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
142
AN: 
139834
Hom.: 
Cov.: 
0
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.000349  AC: 349AN: 998736Hom.:  0  Cov.: 0 AF XY:  0.000369  AC XY: 189AN XY: 511986 show subpopulations  ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
GnomAD4 exome 
 AF: 
AC: 
349
AN: 
998736
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
189
AN XY: 
511986
show subpopulations 
 ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5. 
African (AFR) 
 AF: 
AC: 
0
AN: 
25166
American (AMR) 
 AF: 
AC: 
26
AN: 
41592
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
50
AN: 
21122
East Asian (EAS) 
 AF: 
AC: 
15
AN: 
34030
South Asian (SAS) 
 AF: 
AC: 
30
AN: 
74834
European-Finnish (FIN) 
 AF: 
AC: 
13
AN: 
46510
Middle Eastern (MID) 
 AF: 
AC: 
1
AN: 
4512
European-Non Finnish (NFE) 
 AF: 
AC: 
195
AN: 
707610
Other (OTH) 
 AF: 
AC: 
19
AN: 
43360
 ⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals. 
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.321 
Heterozygous variant carriers
 0 
 24 
 48 
 72 
 96 
 120 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 4 
 8 
 12 
 16 
 20 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.00101  AC: 142AN: 139956Hom.:  0  Cov.: 0 AF XY:  0.000938  AC XY: 63AN XY: 67134 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
142
AN: 
139956
Hom.: 
Cov.: 
0
 AF XY: 
AC XY: 
63
AN XY: 
67134
show subpopulations 
African (AFR) 
 AF: 
AC: 
18
AN: 
38366
American (AMR) 
 AF: 
AC: 
24
AN: 
13522
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
23
AN: 
3314
East Asian (EAS) 
 AF: 
AC: 
3
AN: 
4748
South Asian (SAS) 
 AF: 
AC: 
3
AN: 
4088
European-Finnish (FIN) 
 AF: 
AC: 
5
AN: 
8350
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
278
European-Non Finnish (NFE) 
 AF: 
AC: 
66
AN: 
64506
Other (OTH) 
 AF: 
AC: 
0
AN: 
1906
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.470 
Heterozygous variant carriers
 0 
 6 
 13 
 19 
 26 
 32 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
ClinVar
Significance: Conflicting classifications of pathogenicity 
Submissions summary: Uncertain:1Benign:1 
Revision: criteria provided, conflicting classifications
LINK: link 
Submissions by phenotype
Hypoparathyroidism-retardation-dysmorphism syndrome    Uncertain:1 
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Dec 16, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 PhyloP100 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.